Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 24

NCT04605081

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Naltrexone+Bupropion Medicationn/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • Naltrexone+Bupropion Medication: endpoint not reported
  • Placebo: endpoint not reported